Zhejiang CONBA Pharmaceutical Stock Forecast for 2023 - 2025 - 2030

Updated on 05/12/2024

Stock Rating
13
Price Target
¥3.06
Consensus
Outperform
Downside
-40.35%
Analysts
0
Stock Rating
13
Downside
-40.35%
Analysts
0
Price Target
¥3.06

Zhejiang CONBA Pharmaceutical Stock Forecast and Price Target

The average price target for Zhejiang CONBA Pharmaceutical's stock lately set by several renowned analysts is ¥3.06, which would result in a potential downside of approximately -40.35% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of ¥3.43 and a low estimate of ¥2.72. If interested in 600572 stock, you may also want to consider its competitors.

¥3.06

-40.35% Downside

Outperform
Outperform

Zhejiang CONBA Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030

In the last zero years, Zhejiang CONBA Pharmaceutical's Price has grown, moving from ¥0.00 to ¥0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will jump to ¥6.12 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.

2024 Fair Value Forecast
¥6.12
2025 Fair Value Forecast
¥7.27
2026 Fair Value Forecast
¥7.84
2027 Fair Value Forecast
¥4.62
2028 Fair Value Forecast
¥5.34
2029 Fair Value Forecast
¥6.21
2030 Fair Value Forecast
¥7.08
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
002001 Stock Forecast Zhejiang NHU Outperform 17
¥19.81 Buy/Sell ¥20.23 9.54%
000423 Stock Forecast Dong-E-E-Jiao Buy 14
¥69.09 Buy/Sell ¥57.05 11.45%
688363 Stock Forecast Bloomage BioTechnology Corpora... Outperform 17
¥62.30 Buy/Sell ¥97.00 -0.96%
600521 Stock Forecast Zhejiang Huahai Pharmaceutical Outperform 14
¥17.45 Buy/Sell ¥19.80 11.75%
603707 Stock Forecast Nanjing King-Friend Biochemica... Buy 16
¥13.91 Buy/Sell ¥20.19 45.15%

Zhejiang CONBA Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Zhejiang CONBA Pharmaceutical's Revenue has grown, moving from ¥5.91B to ¥6.00B – an increase of 1.55%. In the next year, analysts predict that Revenue will jump to ¥6.02B – up 0.36% from the current level. Looking ahead to eight years, experts forecast that Revenue will grow by 0.39%.

2023 Rev Forecast
¥6.02B
2024 Rev Forecast
¥5.99B
2025 Rev Forecast
¥6.04B
2026 Rev Forecast
¥6.03B
2027 Rev Forecast
¥6.03B
2028 Rev Forecast
¥6.01B
2029 Rev Forecast
¥6.02B
2030 Rev Forecast
¥6.02B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
000739 Stock Forecast Apeloa Pharmaceutical Co.,Ltd Buy 16
¥15.64 Buy/Sell ¥23.46 13.49%
603456 Stock Forecast Zhejiang Jiuzhou Pharmaceutica... Buy 18
¥16.36 Buy/Sell ¥37.79 44.32%
600267 Stock Forecast Zhejiang Hisun Pharmaceutical Hold 11
¥7.87 Buy/Sell ¥15.60 5.46%

Zhejiang CONBA Pharmaceutical Dividend per Share Forecast for 2023 - 2025 - 2030

In the last year, Zhejiang CONBA Pharmaceutical's Dividend per Share has decreased by 6.25%, going from ¥0.16 to ¥0.15. 2 analysts predict Zhejiang CONBA Pharmaceutical's Dividend per Share will decrease by 6.67% in the next year, reaching ¥0.14. Over the next seven years, experts predict that Zhejiang CONBA Pharmaceutical's Dividend per Share will grow at a rate of 4.40%.

2024 DPS Forecast
¥0.14
2025 DPS Forecast
¥0.16
2026 DPS Forecast
¥0.16
2027 DPS Forecast
¥0.16
2028 DPS Forecast
¥0.15
2029 DPS Forecast
¥0.15
2030 DPS Forecast
¥0.16
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
300705 Stock Forecast Hunan Jiudian Pharmaceutical Buy 16
¥38.25 Buy/Sell ¥36.00 -100.00%
002675 Stock Forecast Yantai Dongcheng Pharmaceutica... Buy 18
¥13.46 Buy/Sell ¥20.30 47.85%
002581 Stock Forecast Shandong Sinobioway Biomedicin... - 9
¥12.63 Buy/Sell ¥0.00 -100.00%

Zhejiang CONBA Pharmaceutical Free Cash Flow Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
603229 Stock Forecast Zhejiang Ausun Pharmaceutical Buy 14
¥10.56 Buy/Sell ¥0.00 -100.00%
002020 Stock Forecast Zhejiang Jingxin Pharmaceutica... Buy 18
¥12.07 Buy/Sell ¥12.30 -100.00%
002099 Stock Forecast Zhejiang Hisoar Pharmaceutical - 14
¥6.34 Buy/Sell ¥13.00 -100.00%

Zhejiang CONBA Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, EBITDA for Zhejiang CONBA Pharmaceutical has grown by 13.13%, going from ¥845.01M to ¥955.99M. In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach ¥1.63B – an increase of 70.77%. Over the next seven years, experts anticipate that EBITDA growth for Zhejiang CONBA Pharmaceutical will be 79.07%.

2024 EBITDA Forecast
¥1.63B
2025 EBITDA Forecast
¥1.91B
2026 EBITDA Forecast
¥1.77B
2027 EBITDA Forecast
¥1.49B
2028 EBITDA Forecast
¥1.55B
2029 EBITDA Forecast
¥1.67B
2030 EBITDA Forecast
¥1.71B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
300363 Stock Forecast Porton Pharma Solutions Outperform 18
¥17.41 Buy/Sell ¥37.00 53.07%
000597 Stock Forecast Northeast Pharmaceutical Group - 16
¥4.89 Buy/Sell ¥0.00 -100.00%
300702 Stock Forecast Zhejiang Tianyu Pharmaceutical Buy 16
¥20.78 Buy/Sell ¥26.00 8.76%

Zhejiang CONBA Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030

Zhejiang CONBA Pharmaceutical's EBIT has grown in the last two years, jumping from ¥586.71M to ¥689.97M – an increase of 17.60%. In the next year, analysts predict that EBIT will reach ¥1.23B – an increase of 78.13%. For the next seven years, the forecast is for EBIT to grow by 96.59%.

2024 EBIT Forecast
¥1.23B
2025 EBIT Forecast
¥1.48B
2026 EBIT Forecast
¥1.45B
2027 EBIT Forecast
¥1.16B
2028 EBIT Forecast
¥1.20B
2029 EBIT Forecast
¥1.30B
2030 EBIT Forecast
¥1.36B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600713 Stock Forecast NanJing Pharmaceutical Company - 16
¥4.92 Buy/Sell ¥11.60 -100.00%
300109 Stock Forecast Boai NKY Medical Holdings - 18
¥16.58 Buy/Sell ¥0.00 -100.00%
300261 Stock Forecast ABA Chemicals - 18
¥6.86 Buy/Sell ¥7.00 -100.00%

Zhejiang CONBA Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last zero years, Zhejiang CONBA Pharmaceutical's EPS has grown, moving from ¥0.00 to ¥0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will jump to ¥0.32 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.

2024 EPS Forecast
¥0.32
2025 EPS Forecast
¥0.38
2026 EPS Forecast
¥0.41
2027 EPS Forecast
¥0.24
2028 EPS Forecast
¥0.28
2029 EPS Forecast
¥0.32
2030 EPS Forecast
¥0.37
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
300497 Stock Forecast Jiangxi Fushine Pharmaceutical - 15
¥8.48 Buy/Sell ¥0.00 -100.00%
000566 Stock Forecast Hainan Haiyao - 8
¥3.70 Buy/Sell ¥14.50 -100.00%
600488 Stock Forecast Tianjin Tianyao Pharmaceutical... - 18
¥4.18 Buy/Sell ¥4.78 -100.00%